TissueLabs
TissueLabs combines 3D bioprinting systems and specialised biomaterials for laboratory tissue research.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Research biofabrication
- Product type
- Device
- Headquarters
- Bellinzona, Switzerland
- Region
- Europe
What they do
The official site lists TissueLabs SA in Bellinzona, Switzerland. Época Negócios describes it as a Brazilian biotech founded by CEO Gabriel Liguori and Emerson Moretto. Its biofabrication platform supplies researchers with 3D bioprinting systems and specialised biomaterials for creating tissues in the lab. The company describes engineering transplantable tissues and organs as a long-term goal, not a current product.
History and progression
How TissueLabs got here, step by step.
10 November 2026
AI and Deep Tech pitch winner
TissueLabs won the TOP AI & Deep Tech Startup Pitch Competition at Unicorn Factory Lisboa during Web Summit week, from 136 applications and seven finalists.
11 November 2026
Second in KPMG global final
As Brazil’s national winner, TissueLabs placed second in the KPMG Private Enterprise Global Tech Innovator 2026 global final in Lisbon.
Sources
Related companies